Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
…, S Gandhi, B Stockinger, J McCauley, SJ Gamblin… - Science, 2020 - science.org
Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in humans.
Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detected …
Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detected …
[HTML][HTML] Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
…, SR Martin, PB Rosenthal, JJ Skehel, SJ Gamblin - Nature, 2020 - nature.com
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is initiated by
virus binding to the ACE2 cell-surface receptors 1 , 2 , 3 – 4 , followed by fusion of the virus …
virus binding to the ACE2 cell-surface receptors 1 , 2 , 3 – 4 , followed by fusion of the virus …
[PDF][PDF] Jarid2 methylation via the PRC2 complex regulates H3K27me3 deposition during cell differentiation
Polycomb Group (PcG) proteins maintain transcriptional repression throughout development,
mostly by regulating chromatin structure. Polycomb Repressive Complex 2 (PRC2), a …
mostly by regulating chromatin structure. Polycomb Repressive Complex 2 (PRC2), a …
Neutralising antibody activity against SARS-CoV-2 VOCs B. 1.617. 2 and B. 1.351 by BNT162b2 vaccination
…, S Hindmarsh, R Beale, A Riddell, S Gamblin… - The Lancet, 2021 - thelancet.com
that emerged in the UK with the second COVID-19 wave in late 2020. The efficacy of currently
licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses 12 …
licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses 12 …
[HTML][HTML] Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
…, Crick COVID-19 Consortium, S Gandhi, S Gamblin… - Nature cancer, 2021 - nature.com
Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune monitoring
(CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in …
(CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in …
[HTML][HTML] The structural basis for 14-3-3: phosphopeptide binding specificity
The 14-3-3 family of proteins mediates signal transduction by binding to phosphoserine-containing
proteins. Using phosphoserine-oriented peptide libraries to probe all mammalian …
proteins. Using phosphoserine-oriented peptide libraries to probe all mammalian …
[HTML][HTML] Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
…, P Cherepanov, D Moore, R Gilson, S Gamblin… - The Lancet, 2020 - thelancet.com
To evaluate these risks, we enrolled 200 patient-facing HCWs between March 26 and April 8,
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …
[PDF][PDF] Structure of the TPR Domain of p67phox in Complex with Rac· GTP
K Lapouge, SJM Smith, PA Walker, SJ Gamblin… - Molecular cell, 2000 - cell.com
p67 phox is an essential part of the NADPH oxidase, a multiprotein enzyme complex that
produces superoxide ions in response to microbial infection. Binding of the small GTPase Rac …
produces superoxide ions in response to microbial infection. Binding of the small GTPase Rac …
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
…, SR Martin, SJ Gamblin… - Proceedings of the …, 2008 - National Acad Sciences
The influenza surface glycoprotein hemagglutinin (HA) is a potential target for antiviral drugs
because of its key roles in the initial stages of infection: receptor binding and the fusion of …
because of its key roles in the initial stages of infection: receptor binding and the fusion of …
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
